These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 24696369)

  • 21. An increase in primary care prescriptions of stop-smoking medication as a result of health insurance coverage in the Netherlands: population based study.
    Verbiest ME; Chavannes NH; Crone MR; Nielen MM; Segaar D; Korevaar JC; Assendelft WJ
    Addiction; 2013 Dec; 108(12):2183-92. PubMed ID: 23819654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of Driving Factors of Willingness to Use and Willingness to Pay for Existing Pharmacological Smoking Cessation Aids Among Young and Middle-Aged Adults in Germany.
    Aumann I; Treskova M; Hagemann N; von der Schulenburg JM
    Appl Health Econ Health Policy; 2016 Aug; 14(4):441-452. PubMed ID: 27021824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medical and pharmacological direct costs of a 9-week smoking cessation programme.
    Wasserfallen JB; Digon P; Cornuz J
    Eur J Prev Cardiol; 2012 Jun; 19(3):565-70. PubMed ID: 21450562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term efficacy of nicotine replacement therapy for smoking cessation in adolescents: a randomized controlled trial.
    Scherphof CS; van den Eijnden RJ; Engels RC; Vollebergh WA
    Drug Alcohol Depend; 2014 Jul; 140():217-20. PubMed ID: 24811201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reach and effectiveness of mailed nicotine replacement therapy for smokers: 6-month outcomes in a naturalistic exploratory study.
    Zawertailo L; Dragonetti R; Bondy SJ; Victor JC; Selby P
    Tob Control; 2013 May; 22(3):e4. PubMed ID: 22496352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of varenicline as an aid to smoking cessation in UK general practice - a THIN database study.
    Blak BT; Wilson K; Metcalfe M; Maguire A; Hards M
    Curr Med Res Opin; 2010 Apr; 26(4):861-70. PubMed ID: 20144137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomised trial of two nicotine patch protocols distributed through a state quitline.
    Burns EK; Hood NE; Goforth E; Levinson AH
    Tob Control; 2016 Mar; 25(2):218-23. PubMed ID: 25416755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Current approaches to smoking cessation].
    Bölcskei PL; Davis-Wagner P; Grundnig J; Pommer P
    Dtsch Med Wochenschr; 2013 Apr; 138(17):902-7. PubMed ID: 23592348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Development, implementation and evaluation of a program for the cessation of smoking for adolescents and young adult smokers].
    Wiborg G; Hanewinkel R; Isensee B; Horn WR
    Gesundheitswesen; 2004 Jul; 66(7):433-8. PubMed ID: 15314735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of a stepped primary care smoking cessation intervention: cluster randomized clinical trial (ISTAPS study).
    Cabezas C; Advani M; Puente D; Rodriguez-Blanco T; Martin C;
    Addiction; 2011 Sep; 106(9):1696-706. PubMed ID: 21561497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of nicotine replacement after a smoking lapse.
    Hughes JR
    Nicotine Tob Res; 2012 Jun; 14(6):751-4. PubMed ID: 21908459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Participation in a population-based physical activity programme as an aid for smoking cessation: a randomised trial.
    Bize R; Willi C; Chiolero A; Stoianov R; Payot S; Locatelli I; Cornuz J
    Tob Control; 2010 Dec; 19(6):488-94. PubMed ID: 20798023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design considerations for a pilot trial using a novel approach for evaluating smoking-cessation medication in methadone-maintained smokers.
    Winhusen T; Theobald J; Lewis D
    Contemp Clin Trials; 2016 Mar; 47():334-9. PubMed ID: 26944021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Smoking cessation course organized by the Italian League for the fight against tumors in Milan and Rome: determinants of cessation after the course and after a year].
    Gorini G; Morasso G; Alberisio A; Bollettini C; Di Iorio A; Gamba A; Malvezzi I; Ottaviano M; Quaranta M; Terrone R; Arcidiacono S
    Epidemiol Prev; 2001; 25(3):113-7. PubMed ID: 11697175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effectiveness of Cytisine versus Nicotine Replacement Treatment for smoking cessation in the Russian Federation.
    Castaldelli-Maia JM; Martins SS; Walker N
    Int J Drug Policy; 2018 Aug; 58():121-125. PubMed ID: 29929154
    [No Abstract]   [Full Text] [Related]  

  • 36. [The readiness of staff in general medical practices to participate in a smoking cessation programme].
    Ulbricht S; Koepsell S; Rumpf HJ; John U; Meyer C
    Gesundheitswesen; 2010; 72(8-9):492-5. PubMed ID: 19798627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of the smoking cessation course (1984-1990) of the Cancer and Lung Society of canton Zurich].
    Gimmi M; Hornung R; Tschopp A; Gutzwiller F
    Soz Praventivmed; 1996; 41(3):158-64. PubMed ID: 8767211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Do patients with cardiopathy stop smoking?].
    Labraca Sánchez JJ; Sánchez Mendoza A; Orozco Beltrán D; Sánchez Ruiz B
    Aten Primaria; 2001 Feb; 27(2):144, 146. PubMed ID: 11256092
    [No Abstract]   [Full Text] [Related]  

  • 39. [Why do our patients really stop smoking?].
    Vila Córcoles A; Rodríguez Pago C; Ochoa Gondar O; Bria Ferré X
    Aten Primaria; 2002 Nov; 30(8):527. PubMed ID: 12427378
    [No Abstract]   [Full Text] [Related]  

  • 40. Smoking and use of mobile phones. Data have been wrongly interpreted.
    Jones T
    BMJ; 2001 Mar; 322(7286):616. PubMed ID: 11269262
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.